This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2025 Sep 9;82(18):959.

doi: 10.1093/ajhp/zxaf194.

The authors reply

Y Vivian Tsai¹, Caitlin Soto¹, Garrett Crawford¹, Kathryn Dzintars¹

Affiliations

PMID: 40726446
DOI: 10.1093/ajhp/zxaf194

Editorial

The authors reply

Y Vivian Tsai et al. Am J Health Syst Pharm. 2025.

. 2025 Sep 9;82(18):959.

doi: 10.1093/ajhp/zxaf194.

Authors

Y Vivian Tsai¹, Caitlin Soto¹, Garrett Crawford¹, Kathryn Dzintars¹

Affiliation

¹ Department of Pharmacy The Johns Hopkins Hospital Baltimore, MD, USA.

PMID: 40726446
DOI: 10.1093/ajhp/zxaf194

No abstract available

PubMed Disclaimer

Comment in

Ceftriaxone dosing in thrice-weekly hemodialysis.
Cardoza C, Lorenzo MP, Housman ST. Cardoza C, et al. Am J Health Syst Pharm. 2025 Sep 9;82(18):957-958. doi: 10.1093/ajhp/zxaf184. Am J Health Syst Pharm. 2025. PMID: 40695552 No abstract available.

Comment on

Ceftriaxone dosing in thrice-weekly hemodialysis.
Cardoza C, Lorenzo MP, Housman ST. Cardoza C, et al. Am J Health Syst Pharm. 2025 Sep 9;82(18):957-958. doi: 10.1093/ajhp/zxaf184. Am J Health Syst Pharm. 2025. PMID: 40695552 No abstract available.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems